0001062993-22-009446.txt : 20220404
0001062993-22-009446.hdr.sgml : 20220404
20220404163318
ACCESSION NUMBER: 0001062993-22-009446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220401
FILED AS OF DATE: 20220404
DATE AS OF CHANGE: 20220404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Evans Elizabeth E.
CENTRAL INDEX KEY: 0001863447
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38624
FILM NUMBER: 22802797
MAIL ADDRESS:
STREET 1: C/O VACCINEX, INC.
STREET 2: 1895 MOUNT HOPE AVENUE
CITY: ROCHESTER
STATE: NY
ZIP: 14620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VACCINEX, INC.
CENTRAL INDEX KEY: 0001205922
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 161603202
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1895 MOUNT HOPE AVE
CITY: ROCHESTER
STATE: NY
ZIP: 14620
BUSINESS PHONE: 585-271-2700
MAIL ADDRESS:
STREET 1: 1895 MOUNT HOPE AVE
CITY: ROCHESTER
STATE: NY
ZIP: 14620
FORMER COMPANY:
FORMER CONFORMED NAME: VACCINEX INC
DATE OF NAME CHANGE: 20021114
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-04-01
0001205922
VACCINEX, INC.
VCNX
0001863447
Evans Elizabeth E.
C/O VACCINEX, INC.
1895 MOUNT HOPE AVENUE
ROCHESTER
NY
14620
0
1
0
0
Chief Operating Officer
Common Stock
9600
D
Stock Option (Right to Buy)
7.1
2025-12-22
Common Stock
9610
9610
D
Stock Option (Right to Buy)
7.1
2025-12-23
Common Stock
8605
8605
D
Stock Option (Right to Buy)
3.9
2029-03-14
Common Stock
12400
12400
D
Stock Option (Right to Buy)
3.82
2030-04-04
Common Stock
10000
10000
D
Stock Option (Right to Buy)
2.93
2031-04-03
Common Stock
8000
8000
D
Stock Option (Right to Buy)
1.29
2022-04-01
4
A
0
20000
0
A
2032-04-01
Common Stock
20000
20000
D
This option is fully exercisable as of the date of this report.
This option has vested with respect to 9,300 shares and the remainder vests on March 15, 2023.
This option has vested with respect to 5,000 shares and the remainder vests in two equal annual installments beginning on April 3, 2023.
This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.
/s/ Scott E. Royer, Attorney-in-Fact for Elizabeth E. Evans
2022-04-04